Association of maternal SARS‐CoV‐2 infection at the time of admission for delivery with labor process and outcomes of vaginal birth: A cohort study

Abstract

AbstractIntroductionThis study aimed to investigate the impact of maternal SARS‐CoV‐2 infection at the time of admission for delivery on labor process and outcomes of vaginal birth.Material and methodsA cohort study was carried out at the Obstetrics Department of Anhui Provincial Hospital, China, where universal reverse transcriptase polymerase chain reaction (RT‐PCR) testing for SARS‐CoV‐2 infection was introduced for all women admitted for labor and delivery from December 1–31, 2022. Women were divided into positive and negative groups based on the test result. All women having a singleton vaginal birth were included in final analysis. The effect of SARS‐CoV‐2 positivity on labor process and outcomes of vaginal birth was estimated by regression analyses.ResultsAmong a total of 360 women included, 87 had a positive SARS‐CoV‐2 test and 273 a negative test. Women in the positive group had an increased likelihood of having longer labor (median 9.3 vs 8.3 hours; sB [log‐transformed] 0.19; 95% confidence interval [CI] 0.09–0.28), episiotomy (39.1% vs 23.8%; adjusted odds ratio [aOR] 2.31; 95% CI 1.27–4.21), grade III meconium‐stained amniotic fluid (19.5% vs 7.0%; aOR 2.52; 95% CI 1.15–5.54) and postpartum hospital stay exceeding 37 hours (58.6% vs 46.5%; aOR 1.71; 95% CI 1.00–2.91). They had reduced rates exclusive breastfeeding (26.7% vs 39%; aOR 0.21; 95% CI 0.09–0.46) as well as mixed feeding (46.5% vs 52.2%; aOR 0.28; 95% CI 0.13–0.60) at 1 week postpartum. No significant differences were observed in other aspects of labor process and birth outcomes, including the uptake of labor analgesia, postpartum hemorrhage (>500 mL) or neonatal outcomes.ConclusionsA positive maternal SARS‐CoV‐2 test in labor among women having vaginal birth was associated with a slightly longer duration of labor, increased likelihood of episiotomy, increased incidence of grade III meconium‐stained amniotic fluid, a longer postpartum hospital stay and a lower rate of breastfeeding 1 week postpartum. However, it did not have an adverse impact on other birth outcomes.